Stock Ratings / Industrials / MLAB / options

EOSE (28) ENVX (31) KRNT (50) GHM (52) ⌘ Pro Terminal →

Mesa Laboratories Inc. (MLAB) Options Positioning, Max Pain & Unusual Sweeps

$133.03 +1.30% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Mesa Laboratories Inc. (MLAB) carries a Roarable Rating of D+ (Sell) with 55/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $744.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE-1.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MLAB)Realized 20D OHLCV Swing Band: ±8.1%

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±8.1%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (MLAB)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for MLAB.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MLAB)

✓Walkthrough of MLAB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MLAB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +33.03%▲ ASCENDING CHANNEL

2026-10-30O $132.4H $133.0L $127.1C $133.0VOL 73.2K

RES: $154.4SUP: $105.9SMA50: $128.5SMA200: $104.2

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MLAB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MLAB Butterfly Map → + Track MLAB →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +3.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MLAB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MLAB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MLAB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MLAB)

Industrials Rank #243 of 485 ⚔️ EOSE vs MLAB Full Matrix →

1. Head-to-Head Industrials Peer Comparison (MLAB vs. EOSE, ENVX, KRNT, GHM)

Industry: Industrial Machinery/Components (208 Tracked Issuers)

Across 485 tracked Industrials securities in the Roarable RQD universe, Mesa Laboratories Inc. (MLAB) ranks #243 by composite RQD confidence (55/100, grade D+) and #273 by equity capitalization ($744.4M). Within this direct 5-issuer industry benchmark cohort, GHM leads on earnings valuation at 67.3x trailing P/E, while GHM leads on capital efficiency and profitability with 10.9% ROIC and 23.5% gross margin. MLAB currently leads its immediate peer cohort in composite quantitative strength at 55/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MLAB ACTIVE Mesa Laboratories Inc.	D+	55/100	110.9x	63.5%	9.3%	+1.30%	$744.4M	Benchmark Subject
EOSE Eos Energy Enterprises Inc. (Class A)	E	28/100	—	-30.0%	-35.0%	+1.54%	$721.1M	/eose-vs-mlab →
ENVX Enovix Corporation	E	31/100	—	19.2%	-20.5%	-0.28%	$770.3M	/envx-vs-mlab →
KRNT Kornit Digital Ltd.	D	50/100	—	44.3%	-4.0%	+0.11%	$780.7M	/krnt-vs-mlab →
GHM Graham Corporation	D+	52/100	67.3x	23.5%	10.9%	+0.75%	$841.4M	/ghm-vs-mlab →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0000724004

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Mesa Laboratories Inc. (MLAB) reported GAAP revenue of $249.1M (+3.4% vs. FY2024 revenue of $241.0M , and +15.2% cumulative change since FY2023) , GAAP net income of $6.7M, operating cash flow of $42.8M, and free cash flow of $39.6M (-7.0% YoY). On the balance sheet, MLAB closed FY2025 with $434.8M in total assets against $0 in total debt (Altman Z-Score: 2.07, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-03-31	$249.1M	$6.7M	$42.8M	$39.6M	$434.8M	—
FY2024 (FY)	2025-03-31	$241.0M	-$2.0M	$46.8M	$42.6M	$433.3M	—
FY2023 (FY)	2024-03-31	$216.2M	-$254.2M	$44.1M	$44.1M	—	—

3. MLAB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Mesa Laboratories Inc. (NASDAQ: MLAB) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $133.03 (+1.30% 1D, market cap $744.4M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 485 tracked Industrials issuers, MLAB ranks #243 in composite RQD confidence.

How does MLAB compare to EOSE and ENVX in the Industrials sector?

Within the Industrials sector (Industrial Machinery/Components), MLAB carries a Roarable D+ (55/100 RQD), trailing P/E of 110.9x, gross margin of 63.5%, and ROIC of 9.3%. By comparison, EOSE (Eos Energy Enterprises Inc. (Class A)) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $721.1M) and ENVX (Enovix Corporation) posts a E grade (31/100 RQD, P/E N/A, ROIC -20.5%, cap $770.3M). Among the 5-stock peer group, GHM leads on earnings multiple (67.3x) while GHM leads on capital efficiency (10.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MLAB?

Per MLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0000724004), Mesa Laboratories Inc. generated $249.1M in revenue (+3.4% YoY), $6.7M in net income, and $39.6M in free cash flow against $434.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Industrials with deep daily trading liquidity.. Primary risk factors monitored: Priced at 111x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MLAB trading relative to its 50-day, 200-day, and 52-week technical levels?

MLAB last traded at $133.03 (+1.30% on volume of 60,937 shares), positioning the stock +3.51% above its 50-day simple moving average ($128.52) and +27.69% above its 200-day simple moving average ($104.18). Across its 52-week range of $69.51 to $144.35, MLAB sits at the 84.9% percentile with a 14-day RSI of 49.0 (NEUTRAL RANGE) and an implied next-earnings move of ±8.1% ($122.25 to $143.81).